MyoPax uses its proprietary muscle stem cell technology to develop advanced regenerative therapies and fight the devastating consequences of muscle diseases.
MyoPax is a spin-off from Charité Universitätsmedizin and Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association.
Company Details
- Employees
- 8
- Address
- Berlin, De
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://myopax.com/
- Keywords
- Muscle Stem Cells, Gene Editing, Muscle regeneration, Muscle diseases, Muscular dystrophies, Rare diseases.
- HQ
- Berlin
Myopax Questions
Myopax's website is https://myopax.com/
Myopax's LinkedIn profile is https://de.linkedin.com/company/myopax
Myopax has
8 employees.
View email and phone details for 8
employees at Myopax.
Myopax's industry is
Biotechnology Research
Myopax's top competitors are
Eleqtron Gmbh,
Vivalyx,
Metismotion,
Captain T Cell,
Biothrust,
Liveeo,
Noah Labs,
Augmented Industries,
Tracebloc,
Invitris.
Myopax's categories are Biotechnology Research
